Page last updated: 2024-08-24

tirofiban and Disease Exacerbation

tirofiban has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, J; Huang, S; Ji, X; Lian, Y; Ma, Q; Ren, M; Song, H; Sun, C; Wang, L; Wang, Y; Wu, C; Wu, D; Xie, N; Zhao, W	1
Glahn, J; Philipps, J; Rother, J; Schwarze, M; Thomalla, G	1
Dykun, Y; Ronner, E; Simoons, ML; van den Brand, MJ; van der Wieken, LR	1
Alexander, J; Barr, E; Ghannam, AF; Pharand, C; Sax, FL; Snapinn, S; Théroux, P	1

Reviews

1 review(s) available for tirofiban and Disease Exacerbation

Article	Year
Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention. European heart journal, 1998, Volume: 19, Issue:11 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Disease Progression; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Tyrosine	1998

Article

Year

Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.

European heart journal, 1998, Volume: 19, Issue:11

Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Disease Progression; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Tyrosine

1998

Trials

2 trial(s) available for tirofiban and Disease Exacerbation

Article	Year
Treatment of progressive stroke with tirofiban--experience in 35 patients. Cerebrovascular diseases (Basel, Switzerland), 2009, Volume: 28, Issue:5 Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine	2009
Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Uns Circulation, 2000, Nov-14, Volume: 102, Issue:20 Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Diabetes Complications; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heparin; Humans; Infusions, Intravenous; Likelihood Functions; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine	2000

Article

Year

Treatment of progressive stroke with tirofiban--experience in 35 patients.

Cerebrovascular diseases (Basel, Switzerland), 2009, Volume: 28, Issue:5

Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2009

Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Uns

Circulation, 2000, Nov-14, Volume: 102, Issue:20

Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Diabetes Complications; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heparin; Humans; Infusions, Intravenous; Likelihood Functions; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine

2000

Other Studies

1 other study(ies) available for tirofiban and Disease Exacerbation

Article	Year
Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis. Stroke, 2019, Volume: 50, Issue:12 Topics: Aged; Disease Progression; Female; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome	2019

Article

Year

Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis.

Stroke, 2019, Volume: 50, Issue:12

Topics: Aged; Disease Progression; Female; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome

2019